Kenneth Glad
For decades, severe eating disorders have stood among the most deadly and stubborn mental health conditions in modern medicine. Traditional treatments often focus heavily on physical stabilization rather than the deep brain patterns driving the illness, leaving many patients trapped in cycles of relapse. Now, an innovative clinical trial in Norway is testing whether rewiring the brain’s threat responses can offer a permanent way out.
Anorexia nervosa carries the highest mortality rate of any psychiatric condition, leaving patients and their families caught in a devastating cycle that often lasts for decades. Standard care in psychiatric facilities typically focuses on physical stabilization, forcing rapid weight restoration through strict feeding regimens to pull patients out of immediate physical danger.
However, these traditional protocols frequently fail to address the deep-seated neurological mechanics driving the illness. When patients return home to their everyday lives, the ingrained, automatic fear of food reasserts itself almost immediately, leading to tragic rates of relapse and widespread despair over the lack of effective long-term treatment.
To tackle this critical care gap, researchers led by psychology professor Bjarne Hansen at the Bergen Center for Brain Plasticity are adapting specialized psychological techniques to break the cycle, writes Norwegian broadcaster NRK. Originally designed to treat severe obsessive-compulsive disorder (OCD) and acute phobias in an intensive four-day format, this concentrated exposure approach gained international recognition for its remarkable success rates.
Rewiring fear signals
The new trial operates on a simple principle: Treating food aversion as an acute phobic reaction, according to NRK. When a patient avoids eating, the brain interprets food as a toxic threat and triggers intense physiological panic.
Clinicians work directly alongside patients during real-world situations, including grocery shopping, meal preparation, and restaurant dining. By forcing the brain to face these triggers without safety behaviors like measuring or calorie counting, the treatment aims to disrupt broken fear loops.
“If you act as if something is dangerous, the body will mobilize feelings as if it is dangerous,” explained Bjarne Hansen to NRK. “We have to change the signals that are sent.”
The strategy is gaining international attention. Mental health institutions in Germany and the United States are monitoring the trial closely, while parallel pilot programs have launched elsewhere in Norway. Psychiatrist Øyvind Rø told the broadcaster that existing outcome metrics remain insufficient across the field, making holistic, brain-focused approaches vital for future care.
Although clinicians emphasize that unravelling years of deep-seated illness takes time, early feedback shows promising shifts in patient behavior and mindset, offering fresh hope for an elusive cure.
Source: NRK
